Clinical Trial Update: An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy. [Phase 3]

View source ↗

Summary

Phase 3 exploratory trial evaluating tocilizumab in rheumatoid arthritis patients with inadequate response to non-biologic DMARDs and/or anti-TNF therapy; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-08-07